Dotrawis MF 80mg/250mg Tablet
Marketer
Delwis Healthcare Pvt Ltd
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Dotrawis MF 80mg/250mg Tablet
Abdominal discomfort is effectively managed by the combined medication, Relpax MF 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, cramping, and general unease by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Administered with food, the dosage and duration of Relpax MF 80mg/250mg Tablet should strictly adhere to your physician's instructions. Treatment should continue as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions are possible. Common, typically transient side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite suppression, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and somnolence are potential effects; avoid activities requiring alertness until the drug's impact is known. Alcohol consumption should be avoided due to increased dizziness risk. Pregnant, breastfeeding, or planning pregnancy individuals, and those with hepatic or renal impairment, should inform their doctor before commencing treatment to ensure appropriate dosage.
Primary Ingredients of Dotrawis MF 80mg/250mg Tablet
No information provided. Therefore, no text can be rewritten.
Uses of Dotrawis MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Dotrawis MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Dotrawis MF 80mg/250mg Tablet whole; do not damage it by chewing, crushing, or breaking. Administer this medication with food.
Common Side effects of Dotrawis MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Dotrawis MF 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dotrawis MF 80mg/250mg tablets should be administered with a meal.
How Dotrawis MF 80mg/250mg Tablet works:
Each Dotrawis MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal muscle spasms. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory substances responsible for abdominal discomfort and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dotrawis MF 80mg/250mg Tablet with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Dotrawis MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dotrawis MF 80mg/250mg Tablet for breastfeeding mothers is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Dotrawis MF 80mg/250mg tablets might lead to adverse reactions, potentially impairing driving ability due to the possibility of dizziness.
KidneyCAUTION
Patients with kidney impairment should use Dotrawis MF 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Dotrawis MF 80mg/250mg Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dotrawis MF 80mg/250mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dotrawis MF 80mg/250mg Tablet :
Should you forget to take your Dotrawis MF 80mg/250mg Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dotrawis MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently